These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18405337)

  • 21. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.
    Kahl-McDonagh MM; Elzer PH; Hagius SD; Walker JV; Perry QL; Seabury CM; den Hartigh AB; Tsolis RM; Adams LG; Davis DS; Ficht TA
    Vaccine; 2006 Jun; 24(24):5169-77. PubMed ID: 16697090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
    Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
    Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.
    Li T; Tong Z; Huang M; Tang L; Zhang H; Chen C
    Can J Microbiol; 2017 Aug; 63(8):719-729. PubMed ID: 28482164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep.
    Zabalza-Baranguá A; San-Román B; Chacón-Díaz C; de Miguel MJ; Muñoz PM; Iriarte M; Blasco JM; Grilló MJ
    Transbound Emerg Dis; 2019 Jan; 66(1):505-516. PubMed ID: 30375177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of defined Brucella melitensis wboA mutants.
    Nikolich MP; Warren RL; Lindler LE; Izadjoo MJ; Hoover DL
    Vaccine; 2010 Oct; 28 Suppl 5():F12-6. PubMed ID: 20362622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
    Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
    Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of immune responses in mice and sheep inoculated with a live attenuated Brucella melitensis REV1 vaccine produced in bioreactor.
    Curina G; Nardini R; Corneli S; D'Avino N; Tentellini M; Montagnoli C; Severi G; Forti K; Paternesi B; Coletti M; Cagiola M
    Vet Immunol Immunopathol; 2018 Apr; 198():44-53. PubMed ID: 29571517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.
    Muñoz PM; de Miguel MJ; Grilló MJ; Marín CM; Barberán M; Blasco JM
    Vaccine; 2008 May; 26(21):2562-9. PubMed ID: 18423950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing
    Bugybayeva D; Ryskeldinova S; Zinina N; Sarmykova M; Assanzhanova N; Kydyrbayev Z; Tabynov K
    Biomed Res Int; 2020; 2020():1438928. PubMed ID: 33274194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous expression of homologous and heterologous antigens in rough, attenuated Brucella melitensis.
    Bandara AB; Poff-Reichow SA; Nikolich M; Hoover DL; Sriranganathan N; Schurig GG; Dobrean V; Boyle SM
    Microbes Infect; 2009 Mar; 11(3):424-8. PubMed ID: 19397881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine.
    Díaz-Aparicio E; Hernández L; Suárez-Güemes F
    Trop Anim Health Prod; 2004 Feb; 36(2):117-21. PubMed ID: 14998310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.
    Arenas-Gamboa AM; Rice-Ficht AC; Kahl-McDonagh MM; Ficht TA
    Infect Immun; 2011 Sep; 79(9):3653-8. PubMed ID: 21708998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
    Motaharinia Y; Rezaee MA; Rashidi A; Jalili A; Rezaie MJ; Shapouri R; Hossieni W; Rahmani MR
    J Microbiol Immunol Infect; 2013 Aug; 46(4):253-8. PubMed ID: 22727892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X; Walters N; Robison A; Trunkle T; Pascual DW
    Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.
    Bugybayeva D; Kydyrbayev Z; Zinina N; Assanzhanova N; Yespembetov B; Kozhamkulov Y; Zakarya K; Ryskeldinova S; Tabynov K
    Infect Dis Poverty; 2021 Feb; 10(1):13. PubMed ID: 33593447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.